Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994-2006)

BMC Microbiology

Volumn 12, Issue , 2012, Pages

  Rubio Lápez, Virginia ^a   Valdezate, Sylvia ^a   Álvarez, David ^a   Villalán, Pilar ^a   Medina, María José ^a   Salcedo, Celia ^a   Sáez Nieto, Juan Antonio ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

emm gene; GAS; Macrolide resistance; PFGE; Tetracycline resistance

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CORRELATIONAL STUDY; GENE FREQUENCY; GENOTYPE; HEMOLYSIS; MOLECULAR CLONING; MOLECULAR EPIDEMIOLOGY; MORPHOLOGY; NONHUMAN; PHENOTYPE; SEROTYPE; SPAIN; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CLUSTER ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; SPAIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TETRACYCLINE;

STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 84868521381     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-12-215     Document Type: Article

References (31)

1. Pathogenesis of group a streptococcal infections. Cunningham MW, Clin Microbiol Rev 2000 13 470 511 10.1128/CMR.13.3.470-511.2000 10885988 (Pubitemid 30452618)
2. Clonal spread of macrolide- and tetracycline-resistant [erm(A) tet(O)] emm77 Streptococcus pyogenes isolates in Italy and Norway. Palmieri C, Vecchi M, Littauer P, et al. Antimicrob Agents Chemother 2006 50 4229 4230 10.1128/AAC.00943-06 17043129 (Pubitemid 44865179)
3. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Seppala H, Skurnik M, Soini H, et al. Antimicrob Agents Chemother 1998 42 257 262 10.1093/jac/42.2.257 9527769 (Pubitemid 28114428)
4. Multiplex PCR for simultaneous detection of macrolide and tetracycline resistance determinants in streptococci. Malhotra-Kumar S, Lammens C, Piessens J, et al. Antimicrob Agents Chemother 2005 49 4798 4800 10.1128/AAC.49.11.4798- 4800.2005 16251336 (Pubitemid 41552624)
5. Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants. Littauer P, Caugant DA, Sangvik M, et al. Antimicrob Agents Chemother 2006 50 1896 1899 10.1128/AAC.50.5.1896-1899.2006 16641473
6. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children. Bingen E, Bidet P, Mihaila-Amrouche L, et al. Antimicrob Agents Chemother 2004 48 3559 3562 10.1128/AAC.48.9.3559-3562.2004 15328126 (Pubitemid 39129360)
7. Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis. Grivea IN, Al Lahham A, Katopodis GD, et al. Antimicrob Agents Chemother 2006 50 256 261 10.1128/AAC.50.1.256-261.2006 16377695 (Pubitemid 43042930)
8. Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region. Montagnani F, Stolzuoli L, Croci L, et al. Infection 2009 37 353 357 10.1007/s15010-008-8023-1 19137242
9. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005. Perez-Trallero E, Montes M, Orden B, et al. Antimicrob Agents Chemother 2007 51 1228 1233 10.1128/AAC.01054-06 17242142 (Pubitemid 46586798)
10. Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal. Silva-Costa C, Ramirez M, Melo-Cristino J, Antimicrob Agents Chemother 2005 49 2109 2111 10.1128/AAC.49.5.2109-2111.2005 15855540 (Pubitemid 40631633)
11. High rate of tetracycline resistance in Streptococcus pyogenes in Iran: an epidemiological study. Jasir A, Tanna A, Noorani A, et al. J Clin Microbiol 2000 38 2103 2107 10834960 (Pubitemid 30414322)
12. Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel. Nir-Paz R, Block C, Shasha D, et al. Int J Antimicrob Agents 2006 28 313 319 10.1016/j.ijantimicag.2006.07.005 16973336 (Pubitemid 44403001)
13. Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003. Reinert RR, Franken C, van Der LM, et al. Int J Antimicrob Agents 2004 24 43 47 10.1016/j.ijantimicag.2004.02.020 15225860 (Pubitemid 38844561)
14. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group a streptococci in the USA. Green MD, Beall B, Marcon MJ, et al. J Antimicrob Chemother 2006 57 1240 1243 10.1093/jac/dkl101 16556634 (Pubitemid 44644434)
15. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types. Michos AG, Bakoula CG, Braoudaki M, et al. Diagn Microbiol Infect Dis 2009 64 295 299 10.1016/j.diagmicrobio.2009.03.004 19395219
16. High prevalence of erythromycin-resistant, clindamycin/miocamycin- susceptible (M phenotype) streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish group for the study of infection in the primary health care setting. Alos JI, Aracil B, Oteo J, et al. J Antimicrob Chemother 2000 45 605 609 10.1093/jac/45.5.605 10797081 (Pubitemid 30255639)
17. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11years (1996-1997 to 2006-2007). Perez-Trallero E, Martin-Herrero JE, Mazon A, et al. Antimicrob Agents Chemother 2010 54 2953 2959 10.1128/AAC.01548-09 20439616
18. Luca B, Ekelund K, Darenberg J, et al. Genetic determinants and epidemiology of antibiotic resistance among invasive isolates of Streptococcus pyogenes in Europe Porto Heli, Greece: Federation European Microbiological Societies Abstract of the XVII lancefield international symposium on streptococci and streptococcal diseases. 2008 164
19. Erythromycin resistance genes in group a streptococci in Finland. Kataja J, Huovinen P, Skurnik M, et al. The Finnish Study Group for Antimicrobial Resistance. Antimicrob Agents Chemother 1999 43 48 52 (Pubitemid 29069198)
20. Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates. Daly MM, Doktor S, Flamm R, et al. J Clin Microbiol 2004 42 3570 3574 10.1128/JCM.42.8.3570-3574.2004 15297499 (Pubitemid 39045682)
21. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A). Malhotra-Kumar S, Mazzariol A, Van Heirstraeten L, et al. J Antimicrob Chemother 2009 63 42 46 18952616
22. SmaI typeability and tetracycline susceptibility and resistance in Streptococcus pyogenes isolates with efflux-mediated erythromycin resistance. Bacciaglia A, Brenciani A, Varaldo PE, et al. Antimicrob Agents Chemother 2007 51 3042 3043 10.1128/AAC.00249-07 17562795 (Pubitemid 47206260)
23. Clonal relationships among isolates of erythromycin-resistant Streptococcus pyogenes of different geographical origin. Kataja J, Huovinen P, Efstratiou A, et al. Eur J Clin Microbiol Infect Dis 2002 21 589 595 10.1007/s10096-002-0771-8 12226689 (Pubitemid 35025017)
24. Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene. Brenciani A, Bacciaglia A, Vecchi M, et al. Antimicrob Agents Chemother 2007 51 1209 1216 10.1128/AAC.01484-06 17261630 (Pubitemid 46586795)
25. Presence of the tet(O) gene in erythromycin- and tetracycline-resistant strains of Streptococcus pyogenes and linkage with either the mef(A) or the erm(A) gene. Giovanetti E, Brenciani A, Lupidi R, et al. Antimicrob Agents Chemother 2003 47 2844 2849 10.1128/AAC.47.9.2844-2849.2003 12936983 (Pubitemid 37040257)
26. Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing: twentieth informational supplement M100-S20 Wayne, PA, USA: CLSI 2010
27. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. Seppala H, Nissinen A, Yu Q, et al. J Antimicrob Chemother 1993 32 885 891 10.1093/jac/32.6.885 8144429 (Pubitemid 24026589)
28. Detection of erythromycin-resistant determinants by PCR. Sutcliffe J, Grebe T, Tait-Kamradt A, et al. Antimicrob Agents Chemother 1996 40 2562 2566 8913465 (Pubitemid 26367644)
29. Molecular basis of resistance to macrolides and lincosamides among staphylococci and streptococci from various animal sources collected in the resistance monitoring program BfT-GermVet. Luthje P, Schwarz S, Int J Antimicrob Agents 2007 29 528 535 10.1016/j.ijantimicag.2006.12.016 17307339 (Pubitemid 46578188)
30. Molecular epidemiology of Streptococcus pyogenes in an area where acute pharyngotonsillitis is endemic. Nguyen L, Levy D, Ferroni A, et al. J Clin Microbiol 1997 35 2111 2114 9230392 (Pubitemid 27318715)
31. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. Perez-Trallero E, Marimon JM, Montes M, et al. Emerg Infect Dis 1999 5 235 240 10.3201/eid0502.990207 10221875 (Pubitemid 29200621)